Tower Research Capital (TRC)’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105K | Buy |
|
|||||
|
2025
Q1 | $19.5K | Sell |
|
|||||
|
2024
Q4 | $336K | Buy |
|
|||||
|
2024
Q3 | $182K | Sell |
|
|||||
|
2024
Q2 | $330K | Buy |
|
|||||
|
2024
Q1 | $44.1K | Buy |
|
|||||
|
2023
Q4 | $33.7K | Buy |
|
|||||
|
2023
Q3 | $20.6K | Sell |
|
|||||
|
2023
Q2 | $71.3K | Buy |
|
|||||
|
2023
Q1 | $22K | Buy |
|
|||||
|
2022
Q4 | $7K | Sell |
|
|||||
|
2022
Q3 | $29K | Sell |
|
|||||
|
2022
Q2 | $452K | Buy |
|
|||||
|
2022
Q1 | $10K | Sell |
|
|||||
|
2021
Q4 | $56K | Buy |
|
|||||
|
2021
Q3 | $36K | Sell |
|
|||||
|
2021
Q2 | $124K | Buy |
|
|||||
|
2021
Q1 | $54K | Buy |
|
|||||
|
2020
Q4 | $16K | Sell |
|
|||||
|
2020
Q3 | $531K | Buy |
|
|||||
|
2020
Q2 | $154K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $4K | Sell |
|
|||||
|
2019
Q2 | $14K | Sell |
|
|||||
|
2019
Q1 | $90K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $7K | Sell |
|
|||||
|
2018
Q2 | $50K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $39K | Buy |
|
|||||
|
2017
Q2 | $1K | Sell |
|
|||||
|
2017
Q1 | $44K | Buy |
|
|||||
|
2016
Q4 | $1K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $10K | Buy |
|
|||||
|
2015
Q4 | $7K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $9K | Buy |
|